Patents by Inventor Lori Karpes

Lori Karpes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ADENO-ASSOCIATED VIRUS FORMULATIONS
    Publication number: 20230090654
    Abstract: Provided herein are pharmaceutical compositions (e.g., formulations) that can provide for the long-term stability of AAV vectors. Also provided herein are methods of making and using the pharmaceutical compositions. The pharmaceutical compositions provided by the present disclosure generally comprise an AAV, histidine, a stabilizing agent, a salt, and a surfactant.
    Type: Application
    Filed: August 24, 2022
    Publication date: March 23, 2023
    Inventors: Lori KARPES, Michael MERCALDI, Eric FAULKNER
  • ADENO-ASSOCIATED VIRUS FORMULATIONS
    Publication number: 20230076072
    Abstract: Provided herein are pharmaceutical compositions (e.g., formulations) that can provide for the long-term stability of AAV vectors. Also provided herein are methods of making and using the pharmaceutical compositions. The pharmaceutical compositions provided by the present disclosure generally comprise an AAV, histidine, a stabilizing agent, a salt, and a surfactant.
    Type: Application
    Filed: August 24, 2022
    Publication date: March 9, 2023
    Inventors: Lori KARPES, Michael Mercaldi, Eric Faulkner
  • FORMULATIONS AND SCREENING OF BIOLOGICAL THERAPEUTIC AGENTS
    Publication number: 20190064147
    Abstract: Provided herein, in some aspects, are methods of developing a biological therapeutic product. The methods can be used to formulate a biological therapeutic agent or screen biological therapeutic agents.
    Type: Application
    Filed: January 18, 2016
    Publication date: February 28, 2019
    Applicant: Biogen MA Inc.
    Inventors: Mark Krebs, Mariana Dimitrova, Kapil Gupta, Shantanu Sule, Randall Mauldin, Adnan Zunic, Lori Karpes
  • Anti-CD40 Antibody Formulations
    Publication number: 20180264112
    Abstract: Provided herein, in some aspects, are low viscosity, low aggregation propensity, high anti-CD40 antibody concentration formulations.
    Type: Application
    Filed: January 15, 2016
    Publication date: September 20, 2018
    Inventors: Mark Krebs, Adnan Zunic, Tia Estey, Shantanu Sule, Margaret McGrath, Lori Karpes, Yana Kravets